Disc Medicine, Inc. (IRON)
91.85
-1.75
(-1.87%)
USD |
NASDAQ |
Dec 12, 16:00
91.82
-0.03
(-0.03%)
After-Hours: 20:00
Disc Medicine Cash from Investing (Quarterly): 49.54M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Revolution Medicines, Inc. | 24.85M |
| Regeneron Pharmaceuticals, Inc. | -402.90M |
| AbbVie, Inc. | -3.264B |
| Artiva Biotherapeutics, Inc. | 16.28M |
| NovaBay Pharmaceuticals, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -47.80M |
| Cash from Financing (Quarterly) | 11.59M |
| Free Cash Flow | -166.03M |
| Free Cash Flow Per Share (Quarterly) | -1.360 |
| Free Cash Flow to Equity (Quarterly) | -47.88M |
| Free Cash Flow to Firm (Quarterly) | -46.91M |
| Free Cash Flow Yield | -5.42% |